Meta's Orion AR Glasses, OpenAI's For-Profit Pivot, and New Blood Type Discovered
Sep 27, 2024
Explore the fascinating world of Meta's Orion AR glasses, featuring silicon carbide lenses and gesture controls for a revolutionary user experience. Dive into the ethical debate surrounding OpenAI's pivot to a for-profit model, raising concerns about the future of AI development. Discover a groundbreaking medical breakthrough with the identification of the rare MAL blood group, solving a 50-year-old mystery that could enhance transfusion safety and personalize patient care. Tune in for insights into tech and medical advancements!
06:07
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
Meta's Orion AR Glasses
Meta's Orion AR glasses prototype uses silicon carbide lenses and a neural wristband.
These lightweight glasses project holograms with a 70-degree field of view and gesture controls.
insights INSIGHT
OpenAI's For-Profit Pivot
OpenAI's shift from nonprofit to for-profit, potentially valuing it at $150 billion, raises ethical concerns.
Critics like Elon Musk oppose this move, citing potential conflicts with OpenAI's mission.
insights INSIGHT
New Blood Type Discovered
The MAL blood group system, a rare blood type, was discovered after a 50-year mystery.
This discovery has implications for transfusion medicine and patient care due to the absence of the AnWj antigen.
Get the Snipd Podcast app to discover more snips from this episode
In this episode of Discover Daily, we begin with Meta's Orion AR glasses prototype, which uses silicon carbide lenses and a neural wristband for intuitive control. These lightweight glasses project holograms onto the real world, offering a 70-degree field of view and gesture controls. While still in development, Orion represents a significant step towards Meta's vision of AR as the future of personal computing.
We also delve into OpenAI's controversial shift from a nonprofit to a for-profit model, potentially valuing the company at $150 billion. This move has sparked debates about AI ethics and development priorities, with critics like Elon Musk calling it "illegal." The restructuring aims to attract investors and compete with tech giants, but raises questions about OpenAI's commitment to its original mission of developing beneficial AI.
Our deep dive focuses on the discovery of the MAL blood group system, solving a 50-year mystery in hematology. This rare blood type, characterized by the absence of the AnWj antigen, has significant implications for transfusion medicine and patient care. The discovery opens new avenues for research in genetic screening, antigen development, and personalized medicine, potentially leading to improved transfusion safety and novel therapeutic approaches.
Perplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you’re interested in.
Take the world's knowledge with you anywhere. Available on iOS and Android
Join our growing Discord community for the latest updates and exclusive content.
Discover Daily by Perplexity